MetaADEDB 2.0 @ LMMD
ifenprodil
(UYNVMODNBIQBMV-UHFFFAOYSA-N)
Structure
SMILES
Oc1ccc(cc1)C(C(N1CCC(CC1)Cc1ccccc1)C)O
Type(s)
Approved; Investigational; Withdrawn
ATC code(s)
C04AX28
Molecular Formula:
C21H27NO2
Molecular Weight:
325.445
Log P:
3.7067
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
43.7
CAS Number(s):
23210-56-2; 23210-58-4
Synonym(s)
1.
ifenprodil
2.
2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-2-methyl-1-ethanol
3.
4-benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-1-piperidineethanol
4.
61 91 RC
5.
Vadilex
6.
ifenprodil hydrochloride
7.
ifenprodil hydrochloride, (+-)-isomer
8.
ifenprodil tartrate
9.
ifenprodil tartrate (1:1), (R*,S*)-(+-)-(R-(R*,R*))-isomer
10.
ifenprodil tartrate (1:1), (R-(R*,R*))-isomer
11.
ifenprodil tartrate (2:1), (R-(R*,R*))-isomer
12.
ifenprodil, (R*,S*)-(+-)-isomer
13.
ifenprodil, tartrate(R-(R*,R*))-isomer
External Link(s)
MeSHC010739
PubChem Compound3689
BindingDB50083351
ChEBI93829
CHEMBLCHEMBL305187
DrugBankDB08954
DrugCentral1419
IUPHAR/BPS Guide to PHARMACOLOGY5472
KEGGdr:D08064
Therapeutic Target DatabaseD08VCI
D0I0DL
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AbscessOFFSIDES
2Acute intermittent porphyriaOFFSIDES
3Alanine Aminotransferase IncreasedOFFSIDES
4Anti-insulin antibody positiveOFFSIDES
5AuraOFFSIDES
6Bacterial antigen positiveOFFSIDES
7Blood alkaline phosphatase increasedOFFSIDES
8Blood amylase increasedOFFSIDES
9Blood electrolytes abnormalOFFSIDES
10Blood glucose fluctuationOFFSIDES
11Blood lactate dehydrogenase increasedOFFSIDES
12Bone marrow depressionOFFSIDES
13Bradycardia1238330CTD
OFFSIDES
14Brain Ischemia2076755CTD
15Cardiovascular insufficiencyOFFSIDES
16Catalepsy15140647CTD
17Cell marker increasedOFFSIDES
18CholecystitisOFFSIDES
19Compression fractureOFFSIDES
20Disseminated Intravascular CoagulationOFFSIDES
21Drug administration errorOFFSIDES
22DysuriaOFFSIDES
23EczemaOFFSIDES
24ErythemaOFFSIDES
25Gamma-Glutamyltransferase IncreasedOFFSIDES
26GlobulinuriaOFFSIDES
27Hallucinations, mixedOFFSIDES
28Hearing Loss8946832CTD
29Hepatic congestionOFFSIDES
30Intestinal PerforationOFFSIDES
31Leukopenia neonatalOFFSIDES
32Lip erosionOFFSIDES
33Lysosomal Storage Diseases28551711CTD
34Markedly reduced dietary intakeOFFSIDES
35Mental impairmentOFFSIDES
36Metastatic painOFFSIDES
37Multi-organ disorderOFFSIDES
38Myasthenia GravisOFFSIDES
39MyelodysplasiaOFFSIDES
40OliguriaOFFSIDES
41PCO2 decreasedOFFSIDES
42PO2 decreasedOFFSIDES
43Pain18155693CTD
44PeritonitisOFFSIDES
45PyelonephritisOFFSIDES
46Respiratory FailureOFFSIDES
47RhabdomyolysisOFFSIDES
48Seizures10698007
19776659
CTD
49Sick Sinus SyndromeOFFSIDES
50SubileusOFFSIDES
51Tachycardia1238330CTD
52Therapy regimen changedOFFSIDES
53Upper respiratory tract inflammationOFFSIDES
54Ventricular FibrillationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.